col blocks we are bridge builder col blocks
COVID Antworten in den wissenschaftlichen Zeitschriften der Welt


15 Ergebisse       Seite 1

 [1] 
Springer-Verlag: Journal of Gastroenterology
  Original Artikel Datum Titel Autoren   Alle Autoren
1 [GO] 2026―Apr―25 Did the COVID-19 pandemic disrupt the continuity of post-SVR surveillance in HCV-cured patients? Hidenori Toyoda, Masanori Atsukawa
2 [GO] 2025―Jul―31 Nationwide epidemiological survey of acute pancreatitis in Japan, 2021: the impact of the COVID-19 pandemic and revised clinical guidelines Yuichi Tanaka, Atsushi Masamune, Ryotaro Matsumoto, Tetsuya Takikawa, Yu Tanaka, Shin Hamada, et al. (+277)
3 [GO] 2024―Jul―09 Reply to “Discrepancies in reported gastrointestinal symptoms in Japanese hospitalized patients with COVID-19 Yuta Matsubara, Hiroki Kiyohara
4 [GO] 2024―Jun―25 Discrepancies in reported gastrointestinal symptoms in Japanese hospitalized patients with COVID-19 Shinji Kuriki, Tsutomu Nishida
5 [GO] 2024―Jan―25 Gastrointestinal symptoms in COVID-19 and disease severity: a Japanese registry-based retrospective cohort study Yuta Matsubara, Hiroki Kiyohara, Yohei Mikami, Kosaku Nanki, Ho Namkoong, Shotaro Chubachi, et al. (+483)
6 [GO] 2023―Nov―16 Editorial: Comparisons of COVID-19-related disturbance in diagnosis of esophagogastric cancer between the Netherlands and Japan Katsunori Iijima, Kenta Watanabe, Yosuke Shimodaira
7 [GO] 2023―Aug―10 Trajectory analyses to identify persistently low responders to COVID-19 vaccination in patients with inflammatory bowel disease: a prospective multicentre controlled study, J-COMBAT Kenji Watanabe, Masanori Nojima, Hiroshi Nakase, Toshiyuki Sato, Minoru Matsuura, Nobuo Aoyama, et al. (+34)
8 [GO] 2023―Jul―31 The impact of the COVID-19 pandemic on the diagnosis, stage, and treatment of esophagogastric cancer Benthe H. Doeve, Jeanne A. C. Bakx, Peter D. Siersema, Camiel Rosman, Nicole C. T. van Grieken, Mark I. van Berge Henegouwen, et al. (+5)
9 [GO] 2023―Jan―06 Anxiety and behavioral changes in Japanese patients with inflammatory bowel disease due to COVID-19 pandemic: a national survey Hiroshi Nakase, Kohei Wagatsuma, Masanori Nojima, Takayuki Matsumoto, Minoru Matsuura, Hideki Iijima, et al. (+28)
10 [GO] 2022―Jan―28 Interim analysis of a multicenter registry study of COVID-19 patients with inflammatory bowel disease in Japan (J-COSMOS) Hiroshi Nakase, Yuki Hayashi, Daisuke Hirayama, Takayuki Matsumoto, Minoru Matsuura, Hideki Iijima, et al. (+75)
11 [GO] 2021―Jul―02 COVID-19-associated liver injury (COVALI): role of hepatologists Yoshio Sumida, Masashi Yoneda
12 [GO] 2021―Apr―17 Correction to: The characteristics of gastrointestinal symptoms in patients with severe COVID-19: a systematic review and meta-analysis Yuki Hayashi, Kohei Wagatsuma, Masanori Nojima, Tsukasa Yamakawa, Tadashi Ichimiya, Yoshihiro Yokoyama, et al. (+3)
13 [GO] 2021―Mrz―23 The characteristics of gastrointestinal symptoms in patients with severe COVID-19: a systematic review and meta-analysis Yuki Hayashi, Kohei Wagatsuma, Masanori Nojima, Tsukasa Yamakawa, Tadashi Ichimiya, Yoshihiro Yokoyama, et al. (+3)
14 [GO] 2021―Feb―01 COVID-19-associated liver injury: from bedside to bench Dongxiao Li, Xiangming Ding, Meng Xie, Dean Tian, Limin Xia
15 [GO] 2020―Aug―09 Significance of liver dysfunction associated with decreased hepatic CT attenuation values in Japanese patients with severe COVID-19 Yoshihito Uchida, Hayato Uemura, Shinpei Yamaba, Daisuke Hamada, Norihito Tarumoto, Shigefumi Maesaki, Satoshi Mochida
 [1] 

15 Ergebisse       Seite 1



[de][en]

Letzte Änderung 2025―Jul―29 14:55:09 UTC

© Daten-Quadrat 2022       Done in 0.006 sec